Jun 22, 2020
BIOLASE, Inc. Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Jun 11, 2020
BIOLASE, Inc. Announces Closing of $6.9 Million Registered Direct Offering Priced At-The-Market
Jun 08, 2020
BIOLASE, Inc. Announces Pricing of $6.9 Million Registered Direct Offering Priced At-The-Market
May 07, 2020
BIOLASE Reports First Quarter 2020 Financial Results
Apr 30, 2020
BIOLASE, Inc to Report First Quarter 2020 Results on May 7, 2020
Mar 24, 2020
BIOLASE Announces Regulatory Clearance of Laser Bacterial Reduction Therapy Indication for Epic Hygiene Laser
Mar 18, 2020
BIOLASE Reschedules Fourth Quarter 2019 Earnings Call To March 26, 2020
Dec 09, 2019
BIOLASE Announces Clearance of the Epic Hygiene Laser for Dental Hygienists
Nov 26, 2019
BIOLASE Announces Schedule Of Investor Conferences In December
Nov 15, 2019
BIOLASE Appoints Michael DiTolla, DDS, FAGD To Its Board Of Directors
Nov 06, 2019
BIOLASE Reports Third Quarter 2019 Results
Oct 31, 2019
BIOLASE Secures $3 Million Revolving Line Of Credit
Oct 24, 2019
BIOLASE Announces Pricing of $8.5 Million Public Offering of Common Stock and Concurrent Private Placement of Convertible Preferred Stock
Oct 23, 2019
BIOLASE Wraps Inaugural Advancing Dentistry Symposium
Oct 21, 2019
BIOLASE Announces Select Preliminary Third Quarter 2019 Financial Results And Date For Reporting Third Quarter 2019 Results
Oct 15, 2019
BIOLASE Announces First-Ever U.S. & Canada Regulatory Clearance of Laser Crown and Veneer Removal
Aug 28, 2019
BIOLASE to Participate at Dougherty & Company Institutional Investor Conference on September 5, 2019
May 16, 2019
BIOLASE Announces Advancing Dentistry Symposium
May 09, 2019
BIOLASE Reports First Quarter 2019 Results
May 06, 2019
BIOLASE, Inc to Report First Quarter 2019 Results on May 9, 2019